Because SerpinA3 is reported to inhibit the progression of fibrosis and HCC, the role of SerpinA3 in preventing the pathogenesis of chronic liver diseases, including NAFLD, merits in-depth studies. This evidence concerns the gene SERPINA3 and metabolic dysfunction-associated steatotic liver disease.